Timothy Kocses, Director, Corporate Technical Accounting, Bristol-Myers Squibb Company to Speak at The Knowledge Group’s The New FASB Lease Accounting Standard

Top Quote The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Timothy Kocses, Director, Corporate Technical Accounting, Bristol-Myers Squibb will speak at its webcast entitled, “The New FASB Lease Accounting Standard: Managing Compliance Challenges.” End Quote
  • (1888PressRelease) September 11, 2019 - This event is scheduled for September 19, 2019 from 12:00 pm to 2:00 pm (ET).

    For further details, please visit:

    About Timothy Kocses
    Since joining BMS in July 2013, Tim has held the role of Director, Corporate Technical Accounting, and leads the global Technical Accounting Network (“TAN”) within the organization. In his role, he supports the Corporate Financial Reporting (“CFR”) group on technical accounting matters, oversees and advises on financial accounting policies, leads BMS’ adoption and implementation efforts for significant accounting changes, helps drive accounting process improvements and efficiencies and provides the technical accounting expertise on all Business Development transactions. He also manages BMS’ Accounting Development Program (“ADP), is a member of the AICPA Business Combinations Task Force, and is an active participant in the Pharma / Biotech Accounting & Reporting Group. In late February 2019, Tim took on the additional role and responsibility of overseeing BMS’ SEC Reporting.

    About Bristol-Myers Squibb Company
    Bristol-Myers Squibb Company is a global specialty biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our strategy is to combine the resources, scale and capability of a pharmaceutical company with the speed and focus on innovation of the biotech industry. Our focus as a specialty biopharmaceutical company is on discovering, developing and delivering transformational medicines for patients facing serious diseases. Our four strategic priorities are to drive business performance, continue to further build a leading franchise in IO, maintain a diversified portfolio both within and outside of IO, and continue our disciplined approach to capital allocation, including establishing partnerships, collaborations and in-licensing or acquiring investigational compounds as an essential component of successfully delivering transformational medicines to patients.

    The new Financial Accounting Standards Board (FASB) ASC 842 lease accounting standard, which took effect on January 1, 2019, involves additional accounting requirements that companies need to prepare to remain compliant with federal regulations. Along with this recent regulatory development is the emergence of new challenges which further complicate FASB lease accounting compliance.

    Aside from securing up-to-date knowledge of the most pressing FASB ASC 842 issues, organizations should also implement a long-term, comprehensive lease accounting and administration solution to efficiently address current and emerging compliance challenges.

    The Knowledge Group has assembled a panel of key thought leaders who will provide an in-depth analysis of the significant implications of this new FASB standard. The speakers will also provide the best practices and practical tips to help companies manage compliance, thus, improving lease management in a cost- and time-effective way.

    About The Knowledge Group
    The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/.

  • FB Icon Twitter Icon In-Icon
Contact Information